E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer (Q73126787)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 February 2003
edit
Language Label Description Also known as
English
E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer
scientific article published on 01 February 2003

    Statements

    E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit